Novavax

-$5.71 (-6.32%) Today

-$1.63 (-1.93%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome.

CEO

Stanley C. Erck

Employees

791

Headquarters

Gaithersburg, Maryland

Founded

1987

NVAX Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

6.34M

High today

$90.98

Low today

$84.55

Open price

$87.65

Volume

5.76M

52 Week high

$331.68

52 Week low

$84.55

NVAX News

BenzingaJan 20

What The Future Might Hold For Novavax Stock - Novavax

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Thursday after Australia’s national drug regulator granted approval for the company's COVID-19 vaccine. T

BenzingaJan 20

Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine

Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The Maryland-

BenzingaJan 18

Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today - Moderna, Novavax

Shares of vaccine makers, including Moderna Inc (NASDAQ:MRNA), BioNTech SE – ADR (NASDAQ:BNTX) and Novavax, Inc. (NASDAQ:NVAX), are trading lower. Move is possi

Analyst ratings

Buy

66.7%

Hold

33.3%

Sell

NVAX Earnings

-$4.75

-$2.59

-$0.43

$1.73

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Feb 28, After Hours

More NVAX News

Barron'sJan 17

Sanofi CEO Says Vaccine Incumbents Will Win the Coming Showdown

Two years ago, vaccines were a sleepy corner of the pharmaceutical industry, dominated by three big pharma firms. The Covid-19 vaccine race changed all that, tu